Adipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling

• by Anke LiuLi, Tongtong Zhang, Zhonghui Feng

• June 24, 2026

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

• by Andrea Surnit

• June 10, 2026

• 4 min

Effects of metabolic syndrome on pulmonary infection in pediatric bronchial asthma: a narrative review

• by Li He, Yang Ye

• June 23, 2026

Gender differences in symptoms suggestive of diabetic gastroparesis in the West Bank: clinical insights from a cross-sectional study

• by Diya Asad, Qusai Zreqat, Shahd T. Idais, Marah Hunjul, Bara'ah Huseein, Alaa Ayyad, Hamzeh M. I. Abugharbieh, Haroun Neiroukh, Areen Zuhour, Salsabeel M. Abukhalaf, Nour Al-Atrash, Roa Alzughayyar, Hussein Hallak

• June 10, 2026